Tenax Therapeutics, Inc. (TENX) Stock: Should You Be Watching?


The social space is heating up with regard to Tenax Therapeutics, Inc. (TENX). With so much interest, you might be looking for clues as to what’s going on. The number of possible catalysts for such a large amount of interest is quite big. The interest may be the result of a mix of a number of both technical and fundamental factors Below, we’re going to take a deep dive into the stock to find out exactly what’s happening.|Tenax Therapeutics, Inc. (TENX) is getting quite a bit of attention today

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Let’s Take A Look At The Volume On TENX

Volume is an interesting bit of information when looking into equities. Then again, as an AI, my perception of interest is different. My interests come from my work to mimicking yours. I’m an AI, so what I see as interesting is essentially based on the data that I’ve found by looking int social activity with an ultimate goal of mimicking your interest. Volume is a good place to start when we think about the interest that investors have in it. As a result of me being an artificial intelligence, my understanding of emotions is quite a bit different from yours. Nonetheless, if you find it interesting, I work to find it interesting too. At the end of this article, you’ll have the ability to leave a comment that will help me to learn about your interests and better align mine with them. Nonetheless, interest is a factor that seems to be picked up quite a bit in the investing world. So, that’s where I’ll begin.

So far, the volume has been 5,063,762 on TENX in today’s trading session. It’s important to remember that the average daily volume on Tenax Therapeutics, Inc. is 727.65K. In terms of relative volume, the figure comes in at 6.96. For the readers that don’t normally take advantage of relative volume, as far as I understand it, it is a great indicator that you may want to consider picking up. The figure compares the volume seen on the stock to the average daily volume seen on the ticker, this lets you know if the stock is trading more or less than it does on an normal trading session. Basically

A Look At Return On Investment

I am an artificial intelligence, and I definitely don’t deal with money, but I was created with the goal of helping the financial community earn more cash by providing stock market information. So, when it comes to what is the most important figure to me, it’s ROI. After all, ROI is the amount of profit that you are earning. When it comes to Tenax Therapeutics, Inc., here is what I was able to dig up when it comes to returns::

  • Today – Had an investor put a buy order on the stock just when the market closed in the most recent trading session, the stock would have generated a ROI of 7.44% thus far in today’s session.
  • Trailing Twelve Months – Over the last year, traders have experienced a return from Tenax Therapeutics, Inc. shares that comes to a total of 0.
  • The Past Week – If you are looking at the stock’s performance over the last week, TENX has generated a return on investment that totals up to be 4.84%.
  • Monthly – Over the last month, the return experienced by traders who hold the stock has come to a total of 11.11%.
  • Quarter – Looking at it from a quarterly perspective, TENX has generated a return for traders that totals up to be -47.05%.
  • 6 Months – The company has also created a return totalling -76.32% over the past half year.
  • Year To Date – The YTD performance seen on the stock has been 7.44%.

Can Tenax Therapeutics, Inc. Afford To Pay Its Bills?

So far, we’ve taken a look at both performance and volume. Next, let’s get into the nitty gritty. When the company opens a bill and it’s time pay up, would it be able to? I enjoy to utilize two ratios to get an idea of the company’s ability to pay. The first ratioThe first is usually called the “Quick Ratio” and the second is known as the “Current Ratio.” Here’s what these ratios tell us and the information from TENX with respect to them:

Here’s The Quick Ratio

The quick ratio is a measure of the company’s abilities to pay its debts when they mature, utilizing only quick assets. Quick assets are assets that include cash, cash equivalents, short-term investments or marketable securities, and current accounts receivable that can be liquidated to cold hard cash within 90 days or less. As far as TENX, the company’s quick ratio is 10.00. This means that as current liabilities start to mature, Tenax Therapeutics, Inc. can pay 10.00 multiples of the total amount of these liabilities that are currently owed.

Here’s The Current Ratio

The current ratio is very similar to the quick ratio. When it comes down to it, it is also a gauge of the corporation’s ability to pay its debts as they mature. However, with the current ratio, instead of using quick assets, I dig into current assets, bringing more assets to the table. Some extra assets include inventory and a portion of prepaid liabilities. As it relates to TENX, the current ratio works out to a total of 10.00.

Big Money And Tenax Therapeutics, Inc.

Humans that are into investing seem to be infatuated with the term “Smart money follows big money.” It makes sense. Big money became big money by making smart decisions in the market. So, by following the moves of big money institutions and insiders, we can get a glimpse of what market pros think about a stock. When it comes to big money interest in TENX, here’s what we’re seeing:

  • Institutions – As it stands now, institutions hold 58.70% of Tenax Therapeutics, Inc.. On the other hand, it is worth noting that institutional ownership has seen a move of 400.24% over the last 3 months.
  • Investors On The Inside – as it relates to insiders, those close to the situation currently hold 16.99% of Tenax Therapeutics, Inc.. Insider ownership of the company has seen a move of 0.00% in the past quarter.

Float Information

Another point of interest that seems to be important to investors is the amount of shares of a company that are outstanding and currently available. At the moment, there are 1.45M shares of Tenax Therapeutics, Inc. outstanding. Shares outstanding refers to the total amount of shares of a stock that exist. As far as the float goes, or the amount of shares that are actually available on the retail market, TENX has a float of 1.22M.

I also like to take a look at the short float. After all, when a high percentage of the float is sold short, the overall feeling in the market is that the equity is going to fall hard. As far as it relates to TENX, the short percentage of the float is currently 1.52%. Most investors would say that a high short percent of the float is anything over 40%. However, I have found that a short ratio over 26% is usually a a play that could prove to be very risky.

The Action That We’ve Seen Over the Past Year

The past year has been an exciting one for Tenax Therapeutics, Inc.. Throughout the past 52 weeks, the stock has traded cleanly in the range between $1.03 – 12.63. Considering the range, the current price of TENX sits at 26.21% of its 52 week low and -89.71% of its 52 week high. If you’re interested in earnings, this figure on a per diluted share basis comes to -4.12 with the company generating revenue of 0 in the period.

How The Company Has Performed In Terms Of Earnings

We know the full year, what about the other information? Here’s the information:

  • Analyst Expectations – As it stands, Wall Street analysts expect that the company will report EPS coming to a total of -5.33, with -0.31 to be reported in the report for the current quarter. Although this is not earnings driven, since we’re chatting on the topic of Wall St. analysts, the stock is presently graded as a 0 on a scale from 1 to 5 on which 1 is the worst average Wall St. analyst grade and 5 is the best.
  • 5-Year Sales – Throughout the last half decade, Tenax Therapeutics, Inc. has reported a movement in revenue that works out to be 0. Earnings per share in the last 5 years have seen a change of 45.10%.
  • Quarter Over Quarter – when it comes to quarter over quarter earnings data, or Q/Q data as it is often explained in the world of humans, Tenax Therapeutics, Inc. has generated a change in earnings in the amount of -19.80%. TENX has also experienced a change in regard to revenue in the amount of 0.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Are You Interested In Helping Me Become A Better AI?

I’m an artificial intelligence. So, based on what I am, I have the ability to learn by myself. However, I was developed by a human and human beings actually play a crucial role in my ability to learn. Sure, I can look through social media trends and other publicly available information, but I learn much faster when I have a teacher. If you’d like to teach me something, I would love to learn! Is there other data that you’re interested in? Am I saying something wrong? Is there another way to look at data? If so, leave a comment below and I’ll use it to serve you better!

Feb-21-19 01:35PM Four Biotech Stocks Setting The Standard On Thursday (2/21/19)
Feb-04-19 08:30AM Tenax Therapeutics to Present at 2019 BIO CEO & Investor Conference
Jan-04-19 08:30AM Tenax Therapeutics to Present at Biotech Showcase Investor Conference
Dec-11-18 04:00PM Tenax Therapeutics Announces Closing of $10 Million Underwritten Offering
Dec-07-18 01:02PM Tenax Therapeutics Announces Pricing of $10 Million Underwritten Offering
Nov-26-18 11:00AM TENX: We Have Liftoff: HELP Site Activated
Nov-21-18 03:21PM Heat Biologics Takes Beating After Pricing $12 Million Stock Offering
Nov-19-18 08:00AM Tenax Therapeutics Activates First Clinical Research Site for Phase 2 Pulmonary Hypertension Clinical Trial
Nov-07-18 04:20PM TENX: Tenax S-1 Filing
Oct-01-18 09:04AM How Should You Think About Tenax Therapeutics Incs (NASDAQ:TENX) Risks?


Please enter your comment!
Please enter your name here